![](https://webarchive.library.unt.edu/web/20080917072022im_/http://www.nci.nih.gov/images/spacer.gif) |
|
Supportive Care Trial Results
1. Zoledronic Acid Prevents Bone Loss During Estrogen-Suppression Treatment of Breast Cancer (Posted: 09/16/2008, Reviewed: 09/16/2008) - Zoledronic acid can prevent treatment-induced bone loss in premenopausal women undergoing total estrogen suppression after surgery for hormone-responsive breast cancer, according to an article published online Jan. 3, 2007, in the Journal of Clinical Oncology.
![](https://webarchive.library.unt.edu/web/20080917072022im_/http://www.nci.nih.gov/images/spacer.gif)
2. IV Iron Effective in Treating Chemotherapy-Induced Anemia (Posted: 04/21/2008) - Two studies in the April 1, 2008, Journal of Clinical Oncology found that intravenous iron significantly improves hemoglobin levels in patients taking erythropoietin-stimulating agents (ESAs) for chemotherapy-induced anemia compared with ESAs alone or ESAs plus oral iron.
![](https://webarchive.library.unt.edu/web/20080917072022im_/http://www.nci.nih.gov/images/spacer.gif)
3. Hypnosis Before Breast-Cancer Surgery Reduces Pain, Discomfort, and Cost (Posted: 09/12/2007) - Women undergoing surgery for breast cancer who received hypnosis before entering the operating room required less anesthesia and pain medication during surgery, and reported less pain, nausea, fatigue, and discomfort after surgery than women who did not receive hypnosis, according to the Sept. 5, 2007, Journal of the National Cancer Institute.
![](https://webarchive.library.unt.edu/web/20080917072022im_/http://www.nci.nih.gov/images/spacer.gif)
4. Granulocyte Colony-Stimulating Factor (G-CSF) Prevents Common Chemotherapy Complication (Posted: 08/15/2007) - A combined analysis confirmed that cancer patients receiving chemotherapy are less likely to suffer febrile neutropenia when they also receive drugs that stimulate white blood cell production, according to the July 20, 2007, Journal of Clinical Oncology.
![](https://webarchive.library.unt.edu/web/20080917072022im_/http://www.nci.nih.gov/images/spacer.gif)
5. Gabapentin Helps Hot Flashes From Prostate Cancer Treatment (Posted: 06/20/2007) - The drug gabapentin (Neurontin®) effectively reduced the intensity and duration of hot flashes in a clinical trial of more than 200 men receiving hormonal treatment for their prostate cancer, according to findings presented at the 2007 ASCO meeting in Chicago.
1 2 3 4 Next > |
|
![](https://webarchive.library.unt.edu/web/20080917072022im_/http://www.nci.nih.gov/images/spacer.gif) |